-+ 0.00%
-+ 0.00%
-+ 0.00%

BeyondSpring Reports Plinabulin Plus Docetaxel Improves Survival in EGFR Wild-Type NSCLC After Checkpoint Inhibitor Failure

Reuters·12/11/2025 12:02:02

Please log in to view news